A. Michael Lincoff

54.6k citations

418 papers · 31.1k indexed · 21 hit papers · h-index 92

Impact in

Internal Medicine top 0.02%
- Venous Thromboembolism Diagnosis and Management
Cardiology and Cardiovascular Medicine top 0.02%
- Acute Myocardial Infarction Research
- Antiplatelet Therapy and Cardiovascular Diseases
- Atrial Fibrillation Management and Outcomes

Papers in

Internal Medicine 73
- Venous Thromboembolism Diagnosis and Management 73
Cardiology and Cardiovascular Medicine 318
- Acute Myocardial Infarction Research 240
- Antiplatelet Therapy and Cardiovascular Diseases 139

Co-authors: Eric J. Topol Stephen J. Nicholls Kathy Wolski Robert A. Harrington Steven E. Nissen Stephen G. Ellis R. Scott Wright Pierre Théroux
Journals: Journal of the American College of Cardiology (68 papers)Circulation (58 papers)The American Journal of Cardiology (48 papers)American Heart Journal (34 papers)European Heart Journal (12 papers)
Partner nations: United States United Kingdom Australia

In The Last Decade

A. Michael Lincoff

406 papers receiving 29.7k citations

Hit Papers

15 papers align trajectories log scale

Design and Rationale of Lp(a)HORIZON Trial: Assessing the Effect of Lipoprotein(a) Lowering With Pelacarsen on Major Cardiovascular Events in Patients With CVD and Elevated Lp(a) 2025 · 21 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2025 American Heart Journal
2024 The Lancet
2024 Nature Medicine
2024 The Lancet
2024 Nature Medicine
2023 New England Journal of Medicine
2023 American Heart Journal
2013 Journal of the American College of Cardiology
2012 Circulation
2012 Journal of the American College of Cardiology
2011 Journal of the American College of Cardiology
2009 New England Journal of Medicine
2008 CHEST Journal
2008 JAMA
2007 Circulation
2007 PubMed
2007 Journal of the American College of Cardiology
2003 JAMA
2000 Circulation
1996 Annals of Internal Medicine
1996 Circulation

Peers

Countries citing papers authored by A. Michael Lincoff

Since Specialization

Citations

This map shows the geographic impact of A. Michael Lincoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Michael Lincoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Michael Lincoff more than expected).

Fields of papers citing papers by A. Michael Lincoff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Michael Lincoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Michael Lincoff. The network helps show where A. Michael Lincoff may publish in the future.

Co-authorship network

The 25 scholars most cited alongside A. Michael Lincoff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with A. Michael Lincoff Line = papers co-authored together A. Michael Lincoff links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The Composite Number Needed to Treat for Semaglutide in Populations with Overweight or Obesity and Established Cardiovascular Disease Without Diabetes Advances in Therapy ·謙吾長浜, Durur Hülya, Ruben Vale, Scott S. Emerson, Miguel L. Grau, Jorge Plutzky, Geraint Roberts, Diego Mundaca, A. Michael Lincoff	2025	2
2	Temporal Trends, Patient Characteristics, and Outcomes of Type 2 Versus Type 1 Myocardial Infarction Among Medicare Beneficiaries Circulation Cardiovascular Quality and Outcomes ·Amgad Mentias, Neil Keshvani, Milind Y. Desai, Samir Kapadia, Khaled M. Ziada, Cian P. McCarthy, X. Liu, Ki Park, Dharam J. Kumbhani, A. Michael Lincoff, James L. Januzzi, Ambarish Pandey	2025	0
3	Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) Journal of the American College of Cardiology ·Subodh Verma, Helen M. Colhoun, Dror Dicker, G. Kees Hovingh, Steven E. Kahn, Alexandra Kautzky‐Willer, Ildiko Lingvay, Jorge Plutzky, Sophie Vlaar, Naveen Rathor, Søren T. Hoff, A. Michael Lincoff	2024	11
4	The Effect of Semaglutide on Mortality and COVID-19–Related Deaths Journal of the American College of Cardiology ·Benjamin M. Scirica, A. Michael Lincoff, Ildiko Lingvay, Paweł Bogdański, Silvio Buscemi, Helen M. Colhoun, Carlos de la Rubia, М. В. Ежов, Søren Hardt‐Lindberg, Ole Kleist Jeppesen, Po-Shu Cheng, Koichi Node, BM Demaerschalk, Hermann Toplak, André P. van Beek, Peter Weeke, Stephen D. Wiviott, John Deanfield, Donna H. Ryan	2024	22
5	Implementing a comprehensive STEMI protocol to improve care metrics and outcomes in patients with in-hospital STEMI: an observational cohort study Open Heart ·Christopher Kanaan, J Conaway, Samuel Prabaharan, Anirudh Kumar, Chetan Huded, S. H. Bennett, Grant W. Reed, Amar Krishnaswamy, A. Michael Lincoff, Jaikirshan Khatri, Rishi Puri, Khaled M. Ziada, Ravi Nair, Samir Kapadia, Umesh N. Khot	2024	1
6	Impact of the COVID‐19 Pandemic on Conduct and Results of CLEAR Outcomes Trial Clinical Cardiology ·Kil-Seok, Luke J. Laffin, Ashish Sarraju, A. Michael Lincoff, Stephen J. Nicholls, LeAnne T. Bloedon, William J. Sasiela, Na Li, Paula Robinson, Stephanie Kelly, Yutaka Shono, Steven E. Nissen	2024	2
7	Inflammation and Cholesterol as Predictors of Cardiovascular Events Among 13 970 Contemporary High-Risk Patients With Statin Intolerance Circulation ·Paul M. Ridker, Lei Lei, Michael J. Louie, Tariq Haddad, Stephen J. Nicholls, A. Michael Lincoff, Peter Libby, Steven E. Nissen, (unknown)	2023	62
8	Femoral Vascular Closure Devices and Bleeding, Hemostasis, and Ambulation Following Percutaneous Coronary Intervention Journal of the American Heart Association ·Guillaume Marquis‐Gravel, Mehnaz Kabeer, Zhen Huang, Steven L. Zelenkofske, A. Michael Lincoff, Roxana Mehran, Philippe Gabríel Steg, Christoph Bode, John H. Alexander, Thomas J. Povsic	2022	8
9	Interaction Between Race and Income on Cardiac Outcomes After Percutaneous Coronary Intervention Journal of the American Heart Association ·Anirudh Kumar, Armando Staudt Manfroi, Umesh N. Khot, Claire E. Raphael, Joanna Ghobrial, Penelope Rampersad, Rishi Puri, Jaikirshan Khatri, Grant W. Reed, Amar Krishnaswamy, Leslie Cho, A. Michael Lincoff, Khaled M. Ziada, Samir Kapadia, Stephen G. Ellis	2022	7
10	Abstract 13721: Impact of COVID-19 Pandemic on Door-to-Balloon Time and Mortality Within a High Reliability STEMI System of Care Circulation ·Weili Zheng, Grant W. Reed, Chetan Huded, Anirudh Kumar, S. H. Bennett, Amar Krishnaswamy, A. Michael Lincoff, Stephen W. Meldon, Damon Kralovic, Samir Kapadia, Umesh N. Khot	2021	0
11	Prognostic implications and outcomes of cardiac arrest among contemporary patients with STEMI treated with PCI Resuscitation Plus ·Anirudh Kumar, Leon Zhou, Chetan Huded, Bovic Kilundu, Venu Menon, Rishi Puri, Grant W. Reed, Ravi Nair, Jaikirshan Khatri, Amar Krishnaswamy, A. Michael Lincoff, Stephen G. Ellis, Khaled M. Ziada, Samir Kapadia, Umesh N. Khot	2021	2
12	Randomised clinical trial: gastrointestinal events in arthritis patients treated with celecoxib, ibuprofen or naproxen in the PRECISION trial Alimentary Pharmacology & Therapeutics ·Neville D. Yeomans, David Y. Graham, M. Elaine Husni, Daniel H. Solomon, Tyler Stevens, John J. Vargo, Taylor Webley, L Wiśniewski, Kathy Wolski, Jeffrey Borer, Peter Libby, A. Michael Lincoff, Thomas F. Lüscher, Weihang Bao, Chris Walker, Steven E. Nissen, (unknown)	2018	35
13	Abstract 17856: Effect of Aspirin on the Cardiovascular, Gastrointestinal, and Renal Safety of Celecoxib, Naproxen, or Ibuprofen Circulation ·Grant W. Reed, Mouin Abdallah, Mingyuan Shao, Kathy Wolski, Venu Menon, A. Michael Lincoff, Steven E. Nissen	2017	1
14	Coronary Artery Bypass Surgery Compared With Percutaneous Coronary Intervention for Proximal Left Anterior Descending Artery Treatment in Patients With Acute Coronary Syndrome: Analysis From the ACUITY Trial. PubMed ·Marco Mennuni, George Dangas, Roxana Mehran, Yanai Ben‐Gal, Ke Xu, Philippe Généreux, Sorin J. Brener, Frederick Feit, A. Michael Lincoff, E. Magnus Ohman, Martial Hamon, Gregg W. Stone	2015	6
15	Incidence and Impact of Totally Occluded Culprit Coronary Arteries in Patients Presenting With Non–ST-Segment Elevation Myocardial Infarction The American Journal of Cardiology ·Josephine Warren, Roxana Mehran, Jennifer Yu, Ke Xu, Michel E. Bertrand, David A. Cox, A. Michael Lincoff, Steven V. Manoukian, E. Magnus Ohman, Stuart Pocock, Harvey D. White, Gregg W. Stone	2014	22
16	Effect of Anemia on Frequency of Short- and Long-Term Clinical Events in Acute Coronary Syndromes (from the Acute Catheterization and Urgent Intervention Triage Strategy Trial) The American Journal of Cardiology ·Vijay Kunadian, Roxana Mehran, A. Michael Lincoff, Frederick Feit, Steven V. Manoukian, Martial Hamon, David Cox, George Dangas, Gregg W. Stone	2014	47
17	Impact of the ACUITY and TIMI major bleeding definitions on one-year mortality in patients with acute coronary syndromes Circulation ·Steven V. Manoukian, Frederick Feit, Michele Voeltz, Ramin Ebrahimi, Martial Hamon, Derek P. Chew, George Dangas, Walter Desmet, A. Michael Lincoff, Jeffrey W. Moses, Charles V. Pollack, James W. Hoekstra, Spencer B. King, Harvey D. White, E. Magnus Ohman, Roxana Mehran, Gregg W. Stone	2007	1
18	Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease Humana Press eBooks ·A. Michael Lincoff	2003	6
19	Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease Humana Press eBooks ·A. Michael Lincoff, Eric J. Topol	1999	6
20	Standard Versus Low-Dose Weight-Adjusted Heparin in Patients Treated With the Platelet Glycoprotein IIb/IIIa Receptor Antibody Fragment Abciximab (c7E3 Fab) During Percutaneous Coronary Revascularization The American Journal of Cardiology ·A. Michael Lincoff, James E. Tcheng, Robert M. Califf, Theodore A. Bass, Jeffrey J. Popma, Paul S. Teirstein, Neal S. Kleiman, 陈学新, H. Vernon Anderson, James J. Ferguson, Catherine F. Cabot, Keaven M. Anderson, Lisa G. Berdan, 越郎笹村, Harlan F. Weisman, Eric J. Topol	1997	98

About A. Michael Lincoff

A. Michael Lincoff is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine, Surgery, Endocrinology, Diabetes and Metabolism and Radiology, Nuclear Medicine and Imaging, having authored 418 papers that have together received 31.1k indexed citations. Recurring topics across this work include Acute Myocardial Infarction Research (240 papers), Antiplatelet Therapy and Cardiovascular Diseases (139 papers), Coronary Interventions and Diagnostics (125 papers), Venous Thromboembolism Diagnosis and Management (73 papers), Cardiac Imaging and Diagnostics (52 papers), Heparin-Induced Thrombocytopenia and Thrombosis (50 papers), Diabetes Treatment and Management (48 papers) and Lipoproteins and Cardiovascular Health (41 papers). The work is most often cited by research in Internal Medicine (5.5k citations), Cardiology and Cardiovascular Medicine (20.8k citations), Surgery (14.0k citations), Endocrinology, Diabetes and Metabolism (4.6k citations) and Radiology, Nuclear Medicine and Imaging (4.6k citations). A. Michael Lincoff has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Eric J. Topol, Stephen J. Nicholls, Kathy Wolski, Robert A. Harrington, Steven E. Nissen, Stephen G. Ellis, R. Scott Wright, Pierre Théroux, Neal S. Kleiman and Nanette K. Wenger. Their work appears in journals such as Journal of the American College of Cardiology, Circulation, The American Journal of Cardiology, American Heart Journal and European Heart Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact